The innovative drug sector of Hong Kong stocks extended its decline into the afternoon session. By the close of trading, Simcere Pharmaceutical had suffered a significant drop of over 11%, while Luye Pharma witnessed a decline of more than 10%. Additionally, Zai Lab and CSPC Pharmaceutical Group recorded falls of over 7% and 6%, respectively.